Evidence map›Paper›PMID 30832446›Full record

ArticleMolecules (Basel, Switzerland)2019

Machine Learning Analyses on Data including Essential Oil Chemical Composition and In Vitro Experimental Antibiofilm Activities against

Alexandros Patsilinakos, Marco Artini, Rosanna Papa, Manuela Sabatino, Mijat Božović, Stefania Garzoli, Gianluca Vrenna, Raissa Buzzi, Stefano Manfredini, Laura Selan and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Novel Antibiofilm Inhibitor Ginkgetin as an Antibacterial Synergist againstInternational journal of molecular sciences · 2022
    Article
  9. Molecules (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
  12. Physicochemical, antioxidant, antibacterial and antibiofilm activity ofVeterinary research forum : an international quarterly journal · 2021
    Article
  13. Anti-Virulence Properties ofMicroorganisms · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Alexandros PatsilinakosRome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University, P.le Aldo Moro 5, 00185 Rome, Italy. alexandros.patsilinakos@uniroma1.it.
Marco ArtiniDepartment of Public Health and Infectious Diseases, Sapienza University, P.le Aldo Moro 5, 00185 Rome, Italy. marco.artini@uniroma1.it.
Rosanna PapaDepartment of Public Health and Infectious Diseases, Sapienza University, P.le Aldo Moro 5, 00185 Rome, Italy. rosanna.papa@uniroma1.it.
Manuela SabatinoAlchemical Dynamics s.r.l., 00125 Rome, Italy. manuela.sabatino@uniroma1.it.
Mijat BožovićFaculty of Natural Sciences and Mathematics, University of Montenegro, Podgorica, Montenegro. gianluca.vrenna@uniroma1.it.
Stefania GarzoliDepartment of Drug Chemistry and Technology, Sapienza University, P.le Aldo Moro 5, 00185 Rome, Italy. mijat.bozovic@uniroma1.it.
Gianluca VrennaDepartment of Public Health and Infectious Diseases, Sapienza University, P.le Aldo Moro 5, 00185 Rome, Italy. stefania.garzoli@uniroma1.it.
Raissa BuzziMaster Course in Cosmetic Sciences, Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy. raissa.buzzi@unife.it.
Stefano ManfrediniMaster Course in Cosmetic Sciences, Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy. smanfred@unife.it.
Laura SelanDepartment of Public Health and Infectious Diseases, Sapienza University, P.le Aldo Moro 5, 00185 Rome, Italy. laura.selan@uniroma1.it.
Rino RagnoRome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University, P.le Aldo Moro 5, 00185 Rome, Italy. rino.ragno@uniroma1.it.
Sapienza University of Rome · ITUniversity of Ferrara · ITUniversity of Montenegro · ME

Funding

Università degli Studi di Ferrara FAR2018
6 · The paper itself

Abstract

Biofilm resistance to antimicrobials is a complex phenomenon, driven not only by genetic mutation induced resistance, but also by means of increased microbial cell density that supports horizontal gene transfer across cells. The prevention of biofilm formation and the treatment of existing biofilms is currently a difficult challenge; therefore, the discovery of new multi-targeted or combinatorial therapies is growing. The development of anti-biofilm agents is considered of major interest and represents a key strategy as non-biocidal molecules are highly valuable to avoid the rapid appearance of escape mutants. Among bacteria, staphylococci are predominant causes of biofilm-associated infections. Staphylococci, especially Staphylococcus aureus (S. aureus) is an extraordinarily versatile pathogen that can survive in hostile environmental conditions, colonize mucous membranes and skin, and can cause severe, non-purulent, toxin-mediated diseases or invasive pyogenic infections in humans. Staphylococcus epidermidis (S. epidermidis) has also emerged as an important opportunistic pathogen in infections associated with medical devices (such as urinary and intravascular catheters, orthopaedic implants, etc.), causing approximately from 30% to 43% of joint prosthesis infections. The scientific community is continuously looking for new agents endowed of anti-biofilm capabilities to fight S. aureus and S epidermidis infections. Interestingly, several reports indicated in vitro efficacy of non-biocidal essential oils (EOs) as promising treatment to reduce bacterial biofilm production and prevent the inducing of drug resistance. In this report were analyzed 89 EOs with the objective of investigating their ability to modulate bacterial biofilm production of different S. aureus and S. epidermidis strains. Results showed the assayed EOs to modulated the biofilm production with unpredictable results for each strain. In particular, many EOs acted mainly as biofilm inhibitors in the case of S. epidermidis strains, while for S. aureus strains, EOs induced either no effect or stimulate biofilm production. In order to elucidate the obtained experimental results, machine learning (ML) algorithms were applied to the EOs' chemical compositions and the determined associated anti-biofilm potencies. Statistically robust ML models were developed, and their analysis in term of feature importance and partial dependence plots led to indicating those chemical components mainly responsible for biofilm production, inhibition or stimulation for each studied strain, respectively.

Indexed as

Anti-Bacterial AgentsBiofilmsHumansMachine LearningMicrobial Sensitivity TestsOils, VolatileStaphylococcal InfectionsStaphylococcusAnti-Bacterial AgentsOils, Volatileantimicrobialbiofilmessential oilmachine learningStaphylococcus species

Identifiers

PMID30832446
PMCPMC6429525
OpenAlexW2919830914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.